
Get exclusive money-saving offers and guides
Straight to your inbox
Posted
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Adherium Limited is a medical devices business based in Australia. Adherium shares (ADR) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Adherium has a trailing 12-month revenue of around $2.2 million.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
Since the stock market crash in March caused by coronavirus, Adherium's share price has had significant negative movement.
Its last market close was $0.023, which is 28.13% down on its pre-crash value of $0.032 and 91.67% up on the lowest point reached during the March crash when the shares fell as low as $0.012.
If you had bought $1,000 worth of Adherium shares at the start of February 2020, those shares would have been worth $472.22 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $638.89.
52-week range | $0.011 - $0.055 |
---|---|
50-day moving average | $0.031 |
200-day moving average | $0.0282 |
Target price | $0.53 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.068 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$0.023 on 2020-10-22
1 week (2021-01-08) | -11.54% |
---|---|
1 month (2020-12-15) | -4.17% |
3 months (2020-10-15) | -23.33% |
6 months (2020-07-15) | 0% |
1 year (2020-01-15) | -25.81% |
---|---|
2 years (2019-01-15) | -32.35% |
3 years (2018-01-15) | -76.29% |
5 years (2016-01-15) | -96.10% |
Revenue TTM | $2.2 million |
---|---|
Gross profit TTM | $1.4 million |
Return on assets TTM | -122.45% |
Return on equity TTM | -540.91% |
Profit margin | 0% |
Book value | 0.006 |
Market capitalisation | $16 million |
TTM: trailing 12 months
We're not expecting Adherium to pay a dividend over the next 12 months.
Over the last 12 months, Adherium's shares have ranged in value from as little as $0.011 up to $0.055. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Adherium's is 2.0037. This would suggest that Adherium's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, North America, and Asia. It offers Hailie, an asthma and COPD medication adherence solution for patients with chronic respiratory diseases. The company also provides a range of smart device sensors for respiratory medications, such as Bluetooth enabled Hailie sensors wrap around a patient's existing inhalers and automatically send usage data to their smartphone; and Hailie app that enables patients, caregivers, and healthcare professionals to track medication adherence, set daily reminders, and discover insights into their medication usage. It offers its digital health solutions to patients, pharmaceutical companies, healthcare providers, and contract research organizations. The company has a collaboration with HGE Health in COPD. The company was founded in 2001 and is headquartered in Auckland, New Zealand.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.